Tilray Target of Unusually Large Options Trading (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) was the recipient of unusually large options trading on Tuesday. Stock investors purchased 65,869 call options on the company. This is an increase of 67% compared to the average volume of 39,407 call options.

Tilray Trading Down 2.1 %

Shares of NASDAQ TLRY traded down $0.03 during midday trading on Thursday, hitting $1.41. The stock had a trading volume of 7,151,338 shares, compared to its average volume of 25,452,771. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of -5.20 and a beta of 2.14. Tilray has a 1-year low of $1.36 and a 1-year high of $2.97. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The company has a fifty day moving average price of $1.66 and a 200 day moving average price of $1.78.

Tilray (NASDAQ:TLRY) last released its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to analyst estimates of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. Tilray’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same period in the previous year, the company posted ($0.10) EPS. On average, analysts predict that Tilray will post -0.14 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm decreased their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.

Hedge Funds Weigh In On Tilray

Several hedge funds and other institutional investors have recently bought and sold shares of TLRY. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Tilray by 6.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company’s stock worth $2,953,000 after purchasing an additional 107,530 shares during the last quarter. CreativeOne Wealth LLC purchased a new stake in Tilray during the 3rd quarter worth approximately $127,000. BNP Paribas Financial Markets increased its holdings in Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after purchasing an additional 1,690,827 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in Tilray by 4.9% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 715,672 shares of the company’s stock worth $1,260,000 after purchasing an additional 33,194 shares during the last quarter. Finally, Bank of Montreal Can increased its holdings in Tilray by 0.3% during the 3rd quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock worth $3,787,000 after purchasing an additional 7,406 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.